Clinical Trial Update: Lipoic Acid for Progressive Multiple Sclerosis (MS) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating alpha-lipoic acid for progressive multiple sclerosis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2025-03-03